FinancialContent

Articles published by Femasys Inc.

< Previous 1 2 3 Next >
News headline image
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Pricing of $8.0 Million Underwritten Public Offering
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Second Quarter Financial Results for 2025
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
News headline image
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
From Femasys Inc.
Via GlobeNewswire
Tickers FEMY
< Previous 1 2 3 Next >